"He’s implying that the because phase II trial had relatively few participants, it’s only really a Phase I."
wow, that's a truly idiotic misinterpretation of what I said.
// if they pass futility in a few weeks and the trial runs to the end as is designed and the endpoints are successful, agree it can satisfy NDA.
// If by accelerated approval you mean getting an approval before the end of the full trial based on just proteinuria result, then I reckon chances of that are slim to zero. it's very likely this trial will need to continue for the full 2 year follow up in all roughly 300 patients to get acceptable eGFR results, that's a few years away. if company had provided a recruitment update/forecast in the 4c as they really should have done imo, investors and analysts would have better idea of progress and likely trial completion time.
// and if they don't pass futility in a few weeks and trial folds, hard to see what the future is for this biotech as there is nothing else in their pipeline as far as I can see and this particular dmx2000 asset has no plausible alternative disease to pursue that I can see.
you can call this "trolling" , I really don't give a flying f##k, but this is how I see the situation , and so do others I've consulted on this.
- Forums
- ASX - By Stock
- DXB
- Ann: Quarterly Appendix 4C and Activities Report
Ann: Quarterly Appendix 4C and Activities Report, page-45
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
52.5¢ |
Change
-0.015(2.78%) |
Mkt cap ! $288.8M |
Open | High | Low | Value | Volume |
53.0¢ | 54.0¢ | 51.0¢ | $1.930M | 3.666M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 136 | 52.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
53.5¢ | 28650 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 136 | 0.525 |
2 | 414653 | 0.520 |
5 | 523978 | 0.515 |
10 | 583975 | 0.510 |
7 | 72242 | 0.505 |
Price($) | Vol. | No. |
---|---|---|
0.535 | 28650 | 2 |
0.540 | 48239 | 2 |
0.545 | 39073 | 3 |
0.550 | 304563 | 12 |
0.555 | 70960 | 3 |
Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |